Back to results
RecruitingPhase 2

Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC

NCT06263543

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

UCLA Jonsson Comprehensive Cancer Center

Los Angeles, California, United States

+2 additional locations

Contact

Reshma L Mahtani, D.O.

(786) 596-2000rmahtani@baptisthealth.net
View on ClinicalTrials.gov
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC — TrialFind